Interesting relevant legal stoush >
State turns on its lawyers over Royal Perth patent ‘betrayal’ (msn.com)
The lawsuit centres around allegations Sturm and her two coworkers unlawfully took the rights to a treatment developed over the course of her 15-year stint at the hospital.The development of an improved method of manufacturing mesenchymal stromal cells, used in the treatment of inflammatory illnesses, was registered in Sturm’s name and that of her capital-raising vehicle Isopogen.
Isopogen raised enough capital to support clinical trials of the patent before it was granted approval in Australia, the United States, South Africa, Japan, Israel, and Singapore.
Cell Therapy News/Articles, page-14517
-
- There are more pages in this discussion • 3,729 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |